Comprehensive Financial Consultants Institutional’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-30,592
Closed -$1.92M 208
2026
Q1
$1.92M Buy
30,592
+1,731
+6% +$121K 0.57% 68
2025
Q4
$1.92M Buy
28,861
+5,313
+23% +$343K 0.58% 64
2025
Q3
$1.58M Buy
23,548
+2,466
+12% +$195K 0.49% 71
2025
Q2
$1.84M Buy
21,082
+8,458
+67% +$663K 0.6% 61
2025
Q1
$862K Buy
12,624
+2,241
+22% +$183K 0.31% 98
2024
Q4
$807K Buy
10,383
+3,049
+42% +$226K 0.29% 100
2024
Q3
$492K Buy
7,334
+874
+14% +$71.8K 0.18% 124
2024
Q2
$732K Buy
6,460
+834
+15% +$105K 0.29% 101
2024
Q1
$780K Buy
+5,626
New +$707K 0.32% 99

Other funds holding DXCM

Comprehensive Financial Consultants Institutional's DXCM Position: Q2 2026 in Review

Comprehensive Financial Consultants Institutional sold out of DexCom (DXCM) in Q2 2026, closing a stake of 30,592 shares — an estimated $1.92M sold.

Comprehensive Financial Consultants Institutional first reported a position in DXCM in Q1 2024 and held it in 9 quarters. The position peaked at $1.92M in Q1 2026. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Comprehensive Financial Consultants Institutional reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Comprehensive Financial Consultants Institutional sold 30,592 DexCom shares in Q2 2026, an estimated $1.92M.
  • Comprehensive Financial Consultants Institutional first reported a position in DexCom in Q1 2024 and held it in 9 quarters.
  • Comprehensive Financial Consultants Institutional's DexCom position peaked at $1.92M in Q1 2026.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Comprehensive Financial Consultants Institutional's 13F filing for Q2 2026, filed 15 Jul 2026.